Sanara MedTech Inc.
SMTI
$31.64
-$0.08-0.25%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -548.65% | -169.50% | -91.72% | -49.78% | 94.22% |
| Total Depreciation and Amortization | 0.62% | 10.64% | 37.55% | 41.92% | 34.45% |
| Total Amortization of Deferred Charges | 1,812.90% | 2,247.62% | -- | -- | -- |
| Total Other Non-Cash Items | 193.20% | 244.47% | 126.06% | 310.27% | -147.01% |
| Change in Net Operating Assets | 150.92% | 223.27% | 29.57% | -23.22% | -253.39% |
| Cash from Operations | 209.84% | 92.70% | 17.90% | 8.44% | -31.55% |
| Capital Expenditure | -32.97% | 94.66% | -355.81% | -137.55% | -1.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -139.41% | 37.14% | -355.81% | -142.80% | 85.60% |
| Total Debt Issued | -- | 57.16% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,791.18% | -71.04% | 91.50% | -0.44% | 79.14% |
| Cash from Financing | -545.99% | 56.47% | 846.07% | -787.68% | 38.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 63.36% | 5,663.69% | 370.93% | -38.65% | 17.92% |